Skip to content
Shorla Oncology: A Leader in Innovative Oncology Solutions
  • About Us
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • Nelarabine Injection
  • Pipeline
    • SH-105
    • SH-110
    • SH-114
  • News
    • Company Updates
    • Media
  • Contact

Manufacture of first GMP batch of SH-111

March 7th 2022May 11th 2020

Read More

Worldwide Association of MBA’s Best Entrepreneurial Venture Award (Private Sector) 2020

April 15th 2021February 7th 2020

Read More

SodEXo Women Mean Business (WMB) Female Newcomer Award 2019

April 15th 2021October 20th 2019

Read More

Ireland’s Best Young Entrepreneur 2019

March 7th 2022September 15th 2019

Read More

Network Ireland Tipperary Businesswoman of the year – Emerging New Business AWARD 2019

April 18th 2021May 24th 2019

Read More

Shorla Oncology visit North Carolina Research Triangle, USA

March 7th 2022November 5th 2018

Read More

Shorla Oncology at SelectUSA Investment Summit, Washington, USA

March 7th 2022July 8th 2018

Read More

Shorla Oncology attending CPhI North America, Philadelphia, USA

March 7th 2022April 18th 2018

Read More

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

Shorla Pharma Ltd trading as Shorla Oncology®

 

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2022

© 2023 Shorla Oncology: A Leader in Innovative Oncology Solutions • Built with GeneratePress
  • About Us
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • Nelarabine Injection
  • Pipeline
    • SH-105
    • SH-110
    • SH-114
  • News
    • Company Updates
    • Media
  • Contact